drugset / Trial / NCT00674063
A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis
RandomizedParallel-groupTriple-blindTreatment
Summary
Comparison of two dosing regimens of Alefacept in subjects weighing between 100kg and 150kg with moderate to severe Chronic Plaque Psoriasis
Timeline
- Start
- 2003-07
- Primary completion
- 2004-04
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | 0.075 mg/kg | — |
| Subject | Alefacept | Protein / enzyme biologic | 7.5 mg | — |